Approval · Notice of Compliance 28124 · 2022
KETOPROFEN: Notice of Compliance 28124
Issued May 10, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28124
- Date
- May 10, 2022
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph as per Advisement Letter. Convert the Product Monograph to the 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KETOPROFEN | Not yet assigned | — |
| KETOPROFEN SR | Not yet assigned | — |
| KETOPROFEN-E | Not yet assigned | — |
Medicinal ingredients
- KETOPROFEN 50 MG per CAP
- KETOPROFEN 200 MG per TAB
- KETOPROFEN 50 MG per TAB
- KETOPROFEN 100 MG per TAB